Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Clinical Significance of Detecting Lymphatic and Blood Vessel Invasion in Stage II Colon Cancer Using Markers D2-40 and CD34 in Combination

  • Lai, Jin-Huo (Department of Oncology, Fujian Medical University Union Hospital, Stem Cell Institute, Fujian Medical University) ;
  • Zhou, Yong-Jian (Department of Oncology, Fujian Medical University Union Hospital, Stem Cell Institute, Fujian Medical University) ;
  • Bin, Du (Department of Oncology, Fujian Medical University Union Hospital, Stem Cell Institute, Fujian Medical University) ;
  • Qiangchen, Qiangchen (Department of Oncology, Fujian Medical University Union Hospital, Stem Cell Institute, Fujian Medical University) ;
  • Wang, Shao-Yuan (Department of Hematology, Fujian Medical University Union Hospital, Stem Cell Institute, Fujian Medical University)
  • Published : 2014.02.01
Download PDF
⟨ Previous Next ⟩

Abstract

This research was conducted to compare differences in colon cancer lymphatic vessel invasion (LVI) with D2-40 antibody labeling and regular HE staining, blood vessel invasion (BVI) with CD34 antibody labeling and HE staining and to assess the possibility of using D2-40-LVI/CD34-BVI in combination for predicting stage II colon cancer prognosis and guiding adjuvant chemotherapy.Anti-D2-40 and anti-CD34 antibodies were applied to tissue samples of 220 cases of stage II colon cancer to label lymphatic vessels and small blood vessels, respectively. LVI and BVI were assessed and multivariate COX regression analysis was performed for associations with colon cancer prognosis. Regular HE staining proved unable to differentiate lymphatic vessels from blood vessels, while D2-40 selectively labeled lymphatic endothelial cell cytosol and CD34 was widely expressed in large and small blood vessels of tumors as well as normal tissues. Compared to regular HE staining, D2-40-labeling for LVI and CD34-labeling for BVI significantly increased positive rate (22.3% vs 10.0% for LVI, and 19.1% vs 9.1% for BVI). Multivariate analysis indicated that TNM stage, pathology tissue type, post-surgery adjuvant chemotherapy, D2-40-LVI, and CD34-BVI were independent factors affecting whole group colon cancer prognosis, while HE staining-BVI, HE staining-LVI were not significantly related. When CD34-BVI/D2-40-LVI were used in combination for detection, the risk of death for patients with two or one positive results was 5.003 times that in the LVI(-)&BVI(-) group (95% CI 2.365 - 9.679). D2-40 antibody LVI labeling and CD34 antibody BVI labeling have higher specificity and accuracy than regular HE staining and can be used as molecular biological indicators for prognosis prediction and guidance of adjuvant chemotherapy for stage II colon cancer.

Keywords

References

  1. Asia Pacific Cohort Studies Collaboration (2007). The role of lifestyle risk factors on mortality from colorectal cancer in populations of the Asia Pacific region-Asian Pacific Cohort Studies Collaboration. Asian Pac J Cancer Prev, 8, 24-6.
  2. Bynum L, Crotty C, and Wilson J (1976). Use of fibrinogen/fibrin degradation products and soluble fibrin complexes for differentiating pulmonary embolism from nonthromboembolic lung disease. Am Rev Respir Dis, 114, 285-289.
  3. Debald M, Polcher M, Flucke U, et al (2010). Increased detection of lymphatic vessel invasion by D2-40 (podoplanin) in early breast cancer: possible influence on patient selection for accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys, 77, 1128-33. https://doi.org/10.1016/j.ijrobp.2009.06.088
  4. Di Tommaso L, Battista S, Destro A, et al (2010). Cracking spaces in Hashimoto Thyroiditis are lymphatic and prelymphatic vessels: a gift of immunohistochemistry for the centenary of Hashimoto's description. Am J Surg Pathol, 34, 1857-61. https://doi.org/10.1097/PAS.0b013e3181fb40fa
  5. Drozdz K, Janczak D, Dziegiel P, et al (2012). Adventitial lymphatics and atherosclerosis. Lymphology, 45, 26-33.
  6. Galon J, Mlecnik B, Bindea G, et al (2013). Towards the introduction of the Immunoscore in the classification of malignant tumors. J Pathol, 232, 199-209.
  7. Kikuchi R, Takano M, Takagi K, et al (1995). Management of early invasive colorectal cancer. Risk of recurrence and clinical guidelines. Dis Colon Rectum, 38, 1286-95. https://doi.org/10.1007/BF02049154
  8. Maak M, Simon I, Nitsche U, et al (2013). Independent validation of a prognostic genomic signature (ColoPrint) for patients with stage II colon cancer. Ann Surg, 257, 1053-58. https://doi.org/10.1097/SLA.0b013e31827c1180
  9. Margaritescu C, Raica M, Pirici D, et al (2010). Podoplanin expression in tumor-free resection margins of oral squamous cell carcinomas: an immunohistochemical and fractal analysis study. Histol Histopathol, 25, 701-711.
  10. Merchant TE, Diamantis PM, Lauwers G, et al (1995). Characterization of malignant colon tumors with 31P nuclear magnetic resonance phospholipid and phosphatic metabolite profiles. Cancer, 76, 1715-23. https://doi.org/10.1002/1097-0142(19951115)76:10<1715::AID-CNCR2820761007>3.0.CO;2-D
  11. Merkow RP, Kmiecik TE, Bentrem DJ, et al (2013). Effect of including cancer-specific variables on models examining short-term outcomes. Cancer, 119, 1412-19. https://doi.org/10.1002/cncr.27891
  12. Mrak K, Eberl T, Laske A, et al (2013). Impact of postoperative complications on long-term survival after resection for rectal cancer. Dis Colon Rectum, 56, 20-28. https://doi.org/10.1097/DCR.0b013e31826f2672
  13. Nakai T, Shimomura T, and Nakai H (2004). A case of isolated pancreatic metastasis of gastric cancer presenting problematic discrimination from gastropancreatic double cancer. Hepatogastroenterology, 51, 1571-74.
  14. Naoi Y, Miyoshi Y, Taguchi T, et al (2007). Connexin26 expression is associated with lymphatic vessel invasion and poor prognosis in human breast cancer. Breast Cancer Res Treat, 106, 11-17. https://doi.org/10.1007/s10549-006-9465-8
  15. Nielsen G. P, Rosenberg A. E, O'Connell J. X, Kattapuram S. V, and Schiller A. L (2011). Tumors and diseases of the joint. Semin Diagn Pathol, 28, 37-52. https://doi.org/10.1053/j.semdp.2011.02.009
  16. Pinho S. S, Matos A. J, Lopes C, et al (2007). Sialyl Lewis x expression in canine malignant mammary tumours: correlation with clinicopathological features and E-cadherin expression. BMC Cancer, 7, 124. https://doi.org/10.1186/1471-2407-7-124
  17. Pruneri G, Ponzoni M, Ferreri A. J, et al (2002). Microvessel density, a surrogate marker of angiogenesis, is significantly related to survival in multiple myeloma patients. Br J Haematol, 118, 817-820. https://doi.org/10.1046/j.1365-2141.2002.03654.x
  18. Rajaganeshan R, Prasad R, Guillou P. J, et al (2007). The influence of invasive growth pattern and microvessel density on prognosis in colorectal cancer and colorectal liver metastases. Br J Cancer, 96, 1112-17. https://doi.org/10.1038/sj.bjc.6603677
  19. Skalova A, Altemani A, Di Palma S, et al (2012). Pleomorphic adenoma of the salivary glands with intravascular tumor deposits: a diagnostic pitfall. Am J Surg Pathol, 36, 1674-82. https://doi.org/10.1097/PAS.0b013e3182690afe
  20. Ueno H, Shirouzu K, Shimazaki H, et al (2013). Histogenesis and prognostic value of myenteric spread in colorectal cancer: a Japanese multi-institutional study. J Gastroenterol.
  21. Van den Eynden GG, Van der Auwera I, Van Laere SJ, et al (2006). Distinguishing blood and lymph vessel invasion in breast cancer: a prospective immunohistochemical study. Br J Cancer, 94, 1643-49.
  22. Wang Y, Zhang X. H, Guo P, Yan L. N, and He, D (2010). [Tumor microvascular density detected by anti-CD105 and anti-CD34 in hepatocellular carcinoma patients and its predictive value of tumor recurrence after liver transplantation]. Sichuan Da Xue Xue Bao Yi Xue Ban, 41, 818-821.

Cited by

  1. Diet and Colorectal Cancer Risk in Asia - a Systematic Review vol.16, pp.13, 2015, https://doi.org/10.7314/APJCP.2015.16.13.5389
  2. Adjuvant Chemotherapy and Prognostic Factors in Stage II Colon Cancer - Izmir Oncology Group Study vol.16, pp.6, 2015, https://doi.org/10.7314/APJCP.2015.16.6.2413